#Celldex Therapeutics (CLDX)

Current News From Three Selected Biotech Firms

Three Biotech Firm in the NEWS Verona Pharma Verona Pharma plc ( VRNA ) announced that senior management will present a company overview at the following conferences in November 2023: Jefferies London...

P

Prohost Biotech

Nov 8, 2023

Treatments for Untreatable Diseases

Prohost Letter #456 Treatments for Untreatable Diseases The revolution in biotechnology is not meant to offer just improvements on approved and marketed drugs. We are witnessing novel investigational...

P

Prohost Biotech

Jul 16, 2023

Celldex Therapeutics Presented Positive Preclinical Data from its TSLP/SCF Bispecific Antibody Program CDX-622 at AAI

Celldex Therapeutics Announcement Celldex Therapeutics ( CLDX ) announced today preclinical data from its CDX-622 bispecific antibody with dual targeting of the alarmin TSLP and stem cell factor ( SCF...

P

Prohost Biotech

May 15, 2023

Celldex Therapeutics: More Promising Results in Treating Chronic Spontaneous Urticaria Refractory to Antihistamines

Celldex Therapeutics Interim Trial Data for Barzolvolimab Interim data from Celldex Therapeutics ( CLDX ) Phase 1b clinical trial of barzolvolimab in patients with moderate to severe chronic spontaneo...

P

Prohost Biotech

Jul 2, 2022

What Happened Over the Past Two Days and Biotech

Some Gains in Biotech Stocks During the War in Europe On Tuesday, Mar 8,2022 the United States’ government decided to ban the importation of Russian oil, liquefied natural gas and coal. This decision...

P

Prohost Biotech

Mar 10, 2022

Some Ideas About the Falling Stock Market Day

The Stock Market Today Before the end of 2021 we recognized that investors were not going to swallow what was reiterated about the strong economy. The fact was there were no criteria for a strong econ...

P

Prohost Biotech

Feb 3, 2022

Devastated and Resurrected Good Biotech Firms: Theravance Biopharma

The Market Devastation and Resurrection of Good Biotech Firms Due to the market’s instability that we have been experiencing for a while now, we decided to look back at some biotech firms whose values...

P

Prohost Biotech

Dec 15, 2021

Celldex Therapeutics Dosed the First Patient in a Phase 1 Study of CDX-0159 for Prurigo Nodularis

Celldex Therapeutics Dosed the First Patient with CDX-0159 for Prurigo Nodularis Celldex Therapeutics ( CLDX ) announced that the first patient in a Phase 1 study of CDX-0159 for prurigo nodularis ( P...

P

Prohost Biotech

Dec 8, 2021

Comprehensive Prohost Letter Issues

The Comprehensive Prohost Letter Issues The Comprehensive Prohost Letter Issues will constitute a chain of 7 issues. Today’s issue will include the following: Pinpointing and selecting the biotech fir...

P

Prohost Biotech

Sep 19, 2021

Companies Behind the Biotechnology Revolution

Prohost Portfolio PLUS #7 Companies Behind The Biotechnology Revolution Without these firms, basic science discoveries in the universities and the academic institutions and by the firms themselves wou...

P

Prohost Biotech

Jul 12, 2021

1m

2

News & Comments

Why Celldex Therapeutics Stock is Soaring

Celldex Therapeutics is Soaring Celldex Therapeutics (CLDX) stock soared following the firm’s announcement of updated data from its ongoing, open-label Phase 1b clinical trial of CDX-0159 in patients...

P

Prohost Biotech

Jul 11, 2021

Intellia Therapeutics and Regeneron Pharmaceuticals: Yes, it is a Miracle!

Prohost Portfolio PLUS #6 Yes, it is a Miracle! Intellia Therapeutics and Regeneron Pharmaceuticals This miracle news from Intellia Therapeutics and Regeneron Pharmaceuticals came Saturday, a day whe...

P

Prohost Biotech

Jun 29, 2021

Celldex Therapeutics See Also: More of Your Questions Answered

Prohost Portfolio PLUS #4 Celldex Therapeutics Celldex Therapeutics ( CLDX ) stock is gaining momentum. On April 12, 2021 Celldex announced its presentation of promising data from its growing bispecif...

P

Prohost Biotech

Apr 26, 2021

Celldex Therapeutics Doses the First Patient with its CDX-0159 Product for Chronic Spontaneous Urticaria

Celldex Therapeutics After an expected resurrection, Celldex Therapeutics ( CLDX ) stock recovered and went as high as over $19 from less than $2 after an exaggerated selloff caused by investors foll...

P

Prohost Biotech

Oct 13, 2020

A Letter to Subscribers

A Letter to Subscribers The complex brutal circumstances we are currently living in has made it imperative that we communicate with you so that you can understand how we at Prohost Biotech are acting...

P

Prohost Biotech

Jun 30, 2020

Good News for Four Companies: Jazz, Celldex, Inventiva & Illumina

Good News for Jazz, Celldex, Inventiva & Illumina Jazz Pharmaceuticals Good News Jazz Pharmaceuticals ( JAZZ ) announced along with its partner PharmaMar (MSE: PHM ) that the U.S. FDA has approved Ze...

P

Prohost Biotech

Jun 17, 2020

1m

8

News & Comments

Celldex Therapeutics: The Beginning of the Firm's Resurrection

Celldex Therapeutics A few years ago Celldex Therapeutics (CLDX) was known for its superior pipeline products. The most promising product in the firm's pipeline was Celldex’s lead drug designed to tre...

P

Prohost Biotech

Jun 12, 2020

End of the Year Decisions ~ Part 1

Prohost Letter #426 End of the Year Decisions ~ Part 1 We decided to make this Prohost Letter a guideline of our opinion regarding all the firms we picked for the Prohost Portfolio, rather than the fe...

P

Prohost Biotech

Jan 15, 2019

Real Breakthroughs

Prohost Letter #420 REAL BREAKTHROUGHS - One Has Already Been Used and the Other Has Extraordinary Promises In the NEWS - THE POWER OF CHECKPOINT INHIBITOR IMMUNOTHERAPY WOW It is about the checkpoi...

P

Prohost Biotech

Apr 17, 2018

Some Good and Bad Stories

The Week in Review #2 The Fairest Upgrades of the Week - Some analysts gave a generous and well measured dose of fairness evaluating biotech firms’ accomplishments. Credit Swiss upgrades Portola Pharm...

P

Prohost Biotech

Aug 27, 2017

1m

2